Clinical Trial Update: Study of Cefepime-zidebactam (FEP-ZID) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating cefepime-zidebactam (FEP-ZID) for complicated urinary tract infection and acute pyelonephritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Urinary Tract Infection
• Pyelonephritis

Drugs mentioned

• Cefepime-zidebactam (FEP-ZID) (cefepime-zidebactam)

Snippet

Sponsor: Wockhardt | Conditions: Complicated Urinary Tract Infection, Acute Pyelonephritis | Phase 3 | Status: COMPLETED